This is a Validated Antibody Database (VAD) review about human prostate specific membrane antigen, based on 8 published articles (read how Labome selects the articles), using prostate specific membrane antigen antibody in all methods. It is aimed to help Labome visitors find the most suited prostate specific membrane antigen antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
prostate specific membrane antigen synonym: FGCP; FOLH; GCP2; GCPII; NAALAD1; NAALAdase; PSM; PSMA; mGCP; glutamate carboxypeptidase 2; N-acetylated alpha-linked acidic dipeptidase 1; N-acetylated-alpha-linked acidic dipeptidase I; NAALADase I; cell growth-inhibiting gene 27 protein; folylpoly-gamma-glutamate carboxypeptidase; glutamate carboxylase II; glutamate carboxypeptidase II; membrane glutamate carboxypeptidase; prostate specific membrane antigen variant F; pteroylpoly-gamma-glutamate carboxypeptidase

Knockout validation
Cell Signaling Technology
rabbit monoclonal (D7I8E)
  • western blot knockout validation; mouse; fig 4a
  • western blot knockout validation; human; loading ...; fig 4a
Cell Signaling Technology prostate specific membrane antigen antibody (Cell Signaling, 12815) was used in western blot knockout validation on mouse samples (fig 4a) and in western blot knockout validation on human samples (fig 4a). Sci Signal (2017) ncbi
Bio-Rad
mouse monoclonal (GCP-04)
  • western blot; human; 1:1000
Bio-Rad prostate specific membrane antigen antibody (AbD Serotec, GCP-04) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
Dako
mouse monoclonal (3E6)
  • immunohistochemistry - frozen section; human; 1:500; fig 1d
Dako prostate specific membrane antigen antibody (Dako, 3E6) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 1d). Int J Mol Sci (2017) ncbi
mouse monoclonal (3E6)
  • immunohistochemistry; human; 1:100; fig s1g
In order to discuss mechanisms involved in the resistance of androgen receptor-targeted therapies, Dako prostate specific membrane antigen antibody (Dako, M3620) was used in immunohistochemistry on human samples at 1:100 (fig s1g). Nat Med (2016) ncbi
mouse monoclonal (3E6)
  • immunohistochemistry - paraffin section; human; 1:50; fig st2
Dako prostate specific membrane antigen antibody (Dako, 3E6) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig st2). Oncotarget (2016) ncbi
mouse monoclonal (3E6)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
Dako prostate specific membrane antigen antibody (Dako, 3E6) was used in immunohistochemistry - paraffin section on human samples (fig 2a). Cancer Immunol Res (2015) ncbi
mouse monoclonal (3E6)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
  • flow cytometry; human; loading ...; fig 4b
  • ELISA; human; loading ...; tbl 3
  • western blot; human; loading ...; fig 1
Dako prostate specific membrane antigen antibody (Dako, M3620) was used in immunohistochemistry - paraffin section on human samples (fig 2), in flow cytometry on human samples (fig 4b), in ELISA on human samples (tbl 3) and in western blot on human samples (fig 1). Prostate (2014) ncbi
mouse monoclonal (3E6)
  • immunohistochemistry - paraffin section; human; 1:50
Dako prostate specific membrane antigen antibody (Dako, M3620) was used in immunohistochemistry - paraffin section on human samples at 1:50. Virchows Arch (2014) ncbi
Cell Signaling Technology
rabbit monoclonal (D7I8E)
  • western blot knockout validation; mouse; fig 4a
  • western blot knockout validation; human; loading ...; fig 4a
Cell Signaling Technology prostate specific membrane antigen antibody (Cell Signaling, 12815) was used in western blot knockout validation on mouse samples (fig 4a) and in western blot knockout validation on human samples (fig 4a). Sci Signal (2017) ncbi
Articles Reviewed
  1. Kristiansen I, Stephan C, Jung K, Dietel M, Rieger A, Tolkach Y, et al. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci. 2017;18: pubmed publisher
  2. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed publisher
  3. Beltran H, Prandi D, Mosquera J, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22:298-305 pubmed publisher
  4. Meller S, Meyer H, Bethan B, Dietrich D, Maldonado S, Lein M, et al. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer. Oncotarget. 2016;7:1421-38 pubmed publisher
  5. Santoro S, Kim S, Motz G, Alatzoglou D, Li C, Irving M, et al. T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer Immunol Res. 2015;3:68-84 pubmed publisher
  6. Lundholm M, Schröder M, Nagaeva O, Baranov V, Widmark A, Mincheva Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE. 2014;9:e108925 pubmed publisher
  7. Tykvart J, Navrátil V, Sedlák F, Corey E, Colombatti M, Fracasso G, et al. Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA). Prostate. 2014;74:1674-90 pubmed publisher
  8. Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65 pubmed publisher